162 related articles for article (PubMed ID: 4782293)
1. Haloperidol in overt ambulatory schizophrenics.
Darling HF
Dis Nerv Syst; 1973; 34(7):364-7. PubMed ID: 4782293
[No Abstract] [Full Text] [Related]
2. Long-term effects of haloperidol.
Man PL
Dis Nerv Syst; 1973 Feb; 34(2):113-8. PubMed ID: 4267586
[No Abstract] [Full Text] [Related]
3. Clinical evaluation in 112 psychiatric patients of a butyrophenone neuroleptic, dehydrobenzperidol (R 4749). A controlled study in 45 patients of dehydrobenzperidol versus haloperidol.
Cocito E; Ambrosini G; Arata A; Bevilacqua P; Tortora E
Arzneimittelforschung; 1970 Aug; 20(8):1119-25. PubMed ID: 4921409
[No Abstract] [Full Text] [Related]
4. Potentiation of haloperidol by -methyldopa in the treatment of schizophrenic patients.
Chouinard G; Serrano PM; Tetreault L
Curr Ther Res Clin Exp; 1973 Jul; 15(7):473-83. PubMed ID: 4198310
[No Abstract] [Full Text] [Related]
5. Sulpiride versus haloperidol in schizophrenia: a double-blind comparative trial.
Cassano GB; Castrogiovanni P; Conti L; Bonollo L
Curr Ther Res Clin Exp; 1975 Feb; 17(2):189-201. PubMed ID: 234359
[No Abstract] [Full Text] [Related]
6. Loxapine succinate: a double-blind comparison with haloperidol and placebo in acute schizophrenics.
Selman FB; McClure RF; Helwig H
Curr Ther Res Clin Exp; 1976 Jun; 19(6):645-52. PubMed ID: 819222
[No Abstract] [Full Text] [Related]
7. Haloperidol: therapeutic window in schizophrenia.
Palao DJ; Arauxo A; Brunet M; Bernardo M; Haro JM; Ferrer J; Gonzalez-Monclus E
J Clin Psychopharmacol; 1994 Oct; 14(5):303-10. PubMed ID: 7806684
[TBL] [Abstract][Full Text] [Related]
8. [Haloperidol decanoate: results of a 6-month open trial in paranoid schizophrenia].
Pérez C; Stier Rosner SE
Acta Psiquiatr Psicol Am Lat; 1989; 35(3-4):111-5. PubMed ID: 2576990
[TBL] [Abstract][Full Text] [Related]
9. Penfluridol (R 16341). A long-acting oral neuroleptic, as maintenance therapy for schizophrenic and mentally retarded patients. A placebo-controlled double-blind trial.
Zwanikken GJ
Psychiatr Neurol Neurochir; 1973; 76(2):83-92. PubMed ID: 4573494
[No Abstract] [Full Text] [Related]
10. [On the position of the butyrophenone derivative Haloperidol in psychiatric treatment].
Greger J; Glitschka A; Müller K
Psychiatr Neurol Med Psychol (Leipz); 1968 Jun; 20(7):241-52. PubMed ID: 5731879
[No Abstract] [Full Text] [Related]
11. Management of hostile, suspicious patients. Trifluoperazine versus haloperidol.
O'Brien CP; DiGiacomo JN; Webb W
Dis Nerv Syst; 1974 Feb; 35(2):75-8. PubMed ID: 17894044
[TBL] [Abstract][Full Text] [Related]
12. Clinical differences among phenothiazines in schizophrenics. Introduction: specific indications for antipsychotics: elusive end of the rainbow.
Hollister LE
Adv Biochem Psychopharmacol; 1974; 9(0):667-73. PubMed ID: 4151921
[No Abstract] [Full Text] [Related]
13. Higher than usual dosage of haloperidol: a pilot study in chronic schizophrenics.
Pacquay M; Brasseur F
Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):46-9. PubMed ID: 798190
[TBL] [Abstract][Full Text] [Related]
14. [Biochemical mechanisms of extrapyramidal-motoric effect of haloperidol in man].
Eben E; Ackenheil M; Raese J; Rüther E
Arzneimittelforschung; 1974 Aug; 24(8):1133-5. PubMed ID: 4479374
[No Abstract] [Full Text] [Related]
15. Advantages and disadvantages of depot-neuroleptics as maintenance medication for chronic schizophrenics.
Möller HJ; Kissling W
Clin Neuropharmacol; 1986; 9 Suppl 4():259-62. PubMed ID: 2882841
[No Abstract] [Full Text] [Related]
16. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
Cesková E; Svestka J
Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306
[TBL] [Abstract][Full Text] [Related]
17. Haloperidol update: 1975.
Ayd FJ
Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):14-22. PubMed ID: 1019142
[No Abstract] [Full Text] [Related]
18. [Treatment of outpatients with high doses of haloperidol].
Shopsin B; Kline N
Acta Psiquiatr Psicol Am Lat; 1981 Jul; 27(3):236-42. PubMed ID: 7348083
[No Abstract] [Full Text] [Related]
19. Clinical pharmacological studies with haloperidol.
Dunlop E
J New Drugs; 1966; 6(4):243-6. PubMed ID: 5968054
[No Abstract] [Full Text] [Related]
20. Haloperidol--new addition to the drug treatment of schizophrenia.
Stewart A; Lafave HG; Segovia G
Behav Neuropsychiatry; 1969 Oct; 1(7):23-8. PubMed ID: 4907607
[No Abstract] [Full Text] [Related]
[Next] [New Search]
